Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00483249 · ClinicalTrials.gov registry record · NA

Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

A NA study of Thoracoabdominal Aortic Aneurysm and Paravisceral Abdominal Aortic Aneurysm, sponsored by Warren J. Gasper, MD.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
2
Study locations

NCT00483249: Recruiting NA study of Thoracoabdominal Aortic Aneurysm and Paravisceral Abdominal Aortic Aneurysm, sponsored by Warren J. Gasper, MD.

NCT00483249 is a NA study of Thoracoabdominal Aortic Aneurysm and Paravisceral Abdominal Aortic Aneurysm that is actively recruiting participants, run by Warren J. Gasper, MD. The registered enrollment target is 250 participants, above the 177-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (41% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00483249, a NA study of Thoracoabdominal Aortic Aneurysm and Paravisceral Abdominal Aortic Aneurysm, is actively recruiting participants, sponsored by Warren J. Gasper, MD.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
2
Study locations

Study Summary

This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

Interventions

  • DEVICE Endovascular Branched Stent-Graft

Study Locations (2)

California

  • Division of Vascular Surgery, SFVAMC - San Francisco
  • Division of Vascular Surgery, UCSF - San Francisco

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2005-05
Est. Completion 2027-12
Phase NA
Warren J. Gasper, MD

1 total trials

What NCT00483249 shows while recruiting

NCT00483249 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 177-participant average among 11 other Thoracoabdominal Aortic Aneurysm trials with a reported enrollment target (41% higher).

The record links to 2 conditions, with Thoracoabdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Endovascular Branched Stent-Graft is the first listed.

NCT00483249 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00483249 about?

NCT00483249 is a clinical study titled "Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm". This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.

What is the current status of trial NCT00483249?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2005-05. Estimated completion is 2027-12.

What conditions does trial NCT00483249 study?

This clinical trial studies the following conditions: Thoracoabdominal Aortic Aneurysm, Paravisceral Abdominal Aortic Aneurysm.

What interventions are being tested in trial NCT00483249?

The interventions under investigation include: Endovascular Branched Stent-Graft (DEVICE).

Who is sponsoring clinical trial NCT00483249?

This trial is sponsored by Warren J. Gasper, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00483249 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thoracoabdominal Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00483249's enrollment target sits among peer trials

250 3rd of 11 higher than 9 of 11 other Thoracoabdominal Aortic Aneurysm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Thoracoabdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

  • NCT02021604 · 250 participants · Phase 1

    Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00483249, the US trial registry maintained by the National Library of Medicine. NCT00483249 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.